View Post

Novel biomarkers predict benefit with immunotherapy in metastatic breast cancer

In Clinical Studies News by Barbara Jacoby

By: European Society for Medical Oncology From: medicalxpress.com Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020. The biomarkers are an increase in the number …